share_log

Nerdy Analyst Ratings

Benzinga ·  Nov 8, 2023 08:24
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
11/08/2023 84.33% Raymond James $5.5 → $4 Maintains Outperform
09/18/2023 268.66% Cantor Fitzgerald → $8 Reiterates Overweight → Overweight
08/28/2023 153.46% Raymond James → $5.5 Reinstates → Outperform
08/21/2023 176.5% JMP Securities → $6 Reiterates Market Outperform → Market Outperform
08/10/2023 130.41% Goldman Sachs $3.75 → $5 Maintains Neutral
08/09/2023 268.66% Cantor Fitzgerald $6 → $8 Maintains Overweight
08/09/2023 130.41% Goldman Sachs $3.75 → $5 Maintains Neutral
08/09/2023 222.58% Needham $5 → $7 Maintains Buy
05/19/2023 130.41% Needham → $5 Reiterates Buy → Buy
05/10/2023 130.41% Needham → $5 Reiterates → Buy
03/06/2023 176.5% Cantor Fitzgerald → $6 Reiterates → Overweight
03/02/2023 61.29% Goldman Sachs $3 → $3.5 Maintains Neutral
03/01/2023 176.5% Cantor Fitzgerald $4 → $6 Maintains Overweight
03/01/2023 61.29% Goldman Sachs $3 → $3.5 Maintains Neutral
03/01/2023 84.33% Raymond James $3.5 → $4 Maintains Outperform
03/01/2023 130.41% Needham → $5 Reiterates → Buy
11/15/2022 38.25% Goldman Sachs $3.5 → $3 Maintains Neutral
11/15/2022 61.29% Raymond James $5 → $3.5 Maintains Outperform
11/15/2022 130.41% Canaccord Genuity $6 → $5 Maintains Buy
10/18/2022 15.21% Barclays $4 → $2.5 Maintains Equal-Weight
08/17/2022 61.29% Goldman Sachs $3 → $3.5 Maintains Neutral
08/16/2022 130.41% Needham $4 → $5 Maintains Buy
06/29/2022 176.5% JP Morgan $7 → $6 Maintains Overweight
05/27/2022 222.58% Canaccord Genuity $8 → $7 Maintains Buy
05/17/2022 130.41% Raymond James $7 → $5 Maintains Outperform
05/17/2022 84.33% Needham $8 → $4 Maintains Buy
05/17/2022 222.58% JMP Securities $11 → $7 Maintains Market Outperform
05/17/2022 38.25% Goldman Sachs $8 → $3 Downgrades Buy → Neutral
03/30/2022 222.58% Cantor Fitzgerald → $7 Initiates Coverage On → Overweight
03/01/2022 268.66% Needham $13 → $8 Maintains Buy
03/01/2022 222.58% Raymond James $9 → $7 Maintains Outperform
03/01/2022 406.91% JMP Securities $13 → $11 Maintains Market Outperform
01/07/2022 268.66% Goldman Sachs → $8 Initiates Coverage On → Buy
11/16/2021 314.75% Raymond James $13 → $9 Maintains Outperform
11/12/2021 453% JP Morgan → $12 Initiates Coverage On → Overweight
10/18/2021 499.08% Needham → $13 Initiates Coverage On → Buy
10/18/2021 499.08% Raymond James → $13 Initiates Coverage On → Outperform
10/18/2021 314.75% Barclays → $9 Initiates Coverage On → Equal-Weight
10/15/2021 499.08% JMP Securities → $13 Initiates Coverage On → Market Outperform
10/04/2021 545.16% Canaccord Genuity → $14 Initiates Coverage On → Buy

What is the target price for Nerdy (NRDY)?

The latest price target for Nerdy (NYSE: NRDY) was reported by Raymond James on November 8, 2023. The analyst firm set a price target for $4.00 expecting NRDY to rise to within 12 months (a possible 84.33% upside). 19 analyst firms have reported ratings in the last year.

What is the most recent analyst rating for Nerdy (NRDY)?

The latest analyst rating for Nerdy (NYSE: NRDY) was provided by Raymond James, and Nerdy maintained their outperform rating.

When is the next analyst rating going to be posted or updated for Nerdy (NRDY)?

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Nerdy, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Nerdy was filed on November 8, 2023 so you should expect the next rating to be made available sometime around November 8, 2024.

Is the Analyst Rating Nerdy (NRDY) correct?

While ratings are subjective and will change, the latest Nerdy (NRDY) rating was a maintained with a price target of $5.50 to $4.00. The current price Nerdy (NRDY) is trading at is $2.17, which is out of the analyst's predicted range.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment